Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension — Stella

Home/Hypertension, Resistant to Conventional Therapy/Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

View on ClinicalTrials.gov

Recruiting

Back to Hypertension, Resistant to Conventional Therapy trials

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

UF Clinical Research Center (UF CRC) - CTSI, Gainesville, Florida

Key details

Phase

Post-approval study

Sponsor

University of Florida

Collaborators

Emory University, National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~120 participants

Started

January 2025

Primary completion

July 2028

Age range

18 Years – 100 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.